These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10738549)

  • 1. Fluorescence-based selection of retrovirally transduced cells in congenital erythropoietic porphyria: direct selection based on the expression of the therapeutic gene.
    Fontanellas A; Mazurier F; Belloc F; Taine L; Dumain P; Morel C; Ged C; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 1999; 1(5):322-30. PubMed ID: 10738549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
    Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
    Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
    Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
    Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells.
    Fontanellas A; Mendez M; Mazurier F; Cario-André M; Navarro S; Ged C; Taine L; Géronimi F; Richard E; Moreau-Gaudry F; Enriquez De Salamanca R; de Verneuil H
    Gene Ther; 2001 Apr; 8(8):618-26. PubMed ID: 11320408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.
    Géronimi F; Richard E; Lamrissi-Garcia I; Lalanne M; Ged C; Redonnet-Vernhet I; Moreau-Gaudry F; de Verneuil H
    J Mol Med (Berl); 2003 May; 81(5):310-20. PubMed ID: 12721665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful gene therapy of mice with congenital erythropoietic porphyria].
    de Verneuil H; Robert-Richard E; Ged C; Mazurier F; Richard E; Moreau-Gaudry F
    Med Sci (Paris); 2008; 24(6-7):615-20. PubMed ID: 18601879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of congenital erythropoietic porphyria.
    Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
    Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A knock-in mouse model of congenital erythropoietic porphyria.
    Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
    Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transfer.
    Moreau-Gaudry F; Ged C; Barbot C; Mazurier F; Boiron JM; Bensidhoum M; Reiffers J; de Verneuil H
    Hum Gene Ther; 1995 Jan; 6(1):13-20. PubMed ID: 7703283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.
    Mazurier F; Moreau-Gaudry F; Salesse S; Barbot C; Ged C; Reiffers J; de Verneuil H
    J Inherit Metab Dis; 1997 Jun; 20(2):247-57. PubMed ID: 9211197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
    Robert-Richard E; Lalanne M; Lamrissi-Garcia I; Guyonnet-Duperat V; Richard E; Pitard V; Mazurier F; Moreau-Gaudry F; Ged C; de Verneuil H
    J Gene Med; 2010 Aug; 12(8):637-46. PubMed ID: 20586119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A model of congenital erythropoietic porphyria for gene transfer in hematopoietic cells].
    de Verneuil H; Moreau-Gaudry F; Ged C
    Transfus Clin Biol; 1997; 4(3):263-6. PubMed ID: 9264783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
    Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal.
    Gorchein A; Guo R; Lim CK; Raimundo A; Pullon HW; Bellingham AJ
    Biomed Chromatogr; 1998; 12(6):350-6. PubMed ID: 9861496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell lines.
    Moreau-Gaudry F; Mazurier F; Bensidhoum M; Ged C; de Verneuil H
    Blood; 1995 Mar; 85(6):1449-53. PubMed ID: 7888667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection.
    Richard E; Mendez M; Mazurier F; Morel C; Costet P; Xia P; Fontanellas A; Geronimi F; Cario-André M; Taine L; Ged C; Malik P; de Verneuil H; Moreau-Gaudry F
    Mol Ther; 2001 Oct; 4(4):331-8. PubMed ID: 11592836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation.
    Harada FA; Shwayder TA; Desnick RJ; Lim HW
    J Am Acad Dermatol; 2001 Aug; 45(2):279-82. PubMed ID: 11464191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.
    Martinez Peinado C; Díaz de Heredia C; To-Figueras J; Arias-Santiago S; Nogueras P; Elorza I; Olivé T; Bádenas C; Moreno MJ; Tercedor J; Herrero C
    Pediatr Dermatol; 2013; 30(4):484-9. PubMed ID: 23557135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature.
    Shaw PH; Mancini AJ; McConnell JP; Brown D; Kletzel M
    Bone Marrow Transplant; 2001 Jan; 27(1):101-5. PubMed ID: 11244446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of oncoretrovirally transduced hematopoietic stem cells and correction through ex vivo expansion.
    Bryder D; Björgvinsdóttir H; Sasaki Y; Jacobsen SE
    J Gene Med; 2005 Feb; 7(2):137-44. PubMed ID: 15538726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.